Manufacturing Biotherapeutics to GMP standard for clinical trials can be one of the most difficult hurdles to overcome. Below are a number of facilities capable of manufacturing clinical and pre-clinical grade therapeutics including plasmid, oligonucleotides and viral vectors. There are also a selection of facilities capable of conducting the range of tests necessary to meet safety standards.
Viral Vector Production Unit
The growing role of academia in clinical translation of gene and cell therapies
CRISPR, ready, go!!
A step towards treatment of congenital deafness with gene therapy
Treating allergy with a single vaccine?
Copyright ©2016 European Society for Gene and Cell Therapy | Website by OFEC